SPIA
RPRX icon

Steward Partners Investment Advisory’s Royalty Pharma RPRX Stock Holding History

Steward Partners Investment Advisory’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Sell
4,462
-2,348
-34% -$122K ﹤0.01% 2107
2026
Q1 		$327K Sell
6,810
-82
-1% -$3.59K ﹤0.01% 1763
2025
Q4 		$266K Buy
6,892
+123
+2% +$4.69K ﹤0.01% 1776
2025
Q3 		$239K Buy
6,769
+41
+0.6% +$1.48K ﹤0.01% 1779
2025
Q2 		$242K Sell
6,728
-934
-12% -$30.9K ﹤0.01% 1663
2025
Q1 		$239K Buy
7,662
+3,231
+73% +$102K ﹤0.01% 1567
2024
Q4 		$113K Buy
4,431
+3,942
+806% +$105K ﹤0.01% 1917
2024
Q3 		$13.8K Buy
489
+84
+21% +$2.33K ﹤0.01% 2819
2024
Q2 		$10.7K Buy
405
+3
+0.7% +$83 ﹤0.01% 2799
2024
Q1 		$12.2K Buy
402
+211
+110% +$6.22K ﹤0.01% 2732
2023
Q4 		$5.36K Buy
191
+2
+1% +$55 ﹤0.01% 2934
2023
Q3 		$5.14K Buy
189
+1
+0.5% +$30 ﹤0.01% 2812
2023
Q2 		$5.78K Sell
188
-24
-11% -$813 ﹤0.01% 2748
2023
Q1 		$7.64K Buy
212
+21
+11% +$779 ﹤0.01% 2642
2022
Q4 		$7.54K Buy
191
+6
+3% +$250 ﹤0.01% 2625
2022
Q3 		$7K Hold
185
– – ﹤0.01% 2662
2022
Q2 		$8K Hold
185
– – ﹤0.01% 2606
2022
Q1 		$7K Hold
185
– – ﹤0.01% 2791
2021
Q4 		$7K Buy
+185
New +$7.19K ﹤0.01% 2735

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Steward Partners Investment Advisory's RPRX Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Royalty Pharma (RPRX) stake by 34% in Q2 2026, selling an estimated $122K and leaving 4,462 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #2107.

Steward Partners Investment Advisory first reported a position in RPRX in Q4 2021 and has held it in 19 quarters since. The position peaked at $327K in Q1 2026. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Steward Partners Investment Advisory held 4,462 shares of Royalty Pharma worth $250K as of Q2 2026.
  • Steward Partners Investment Advisory sold 2,348 Royalty Pharma shares in Q2 2026, an estimated $122K.
  • Royalty Pharma made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2107 holding.
  • Steward Partners Investment Advisory first reported a position in Royalty Pharma in Q4 2021 and has held it in 19 quarters since.
  • Steward Partners Investment Advisory's Royalty Pharma position peaked at $327K in Q1 2026.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.